肌萎缩性肥胖
医学
泌尿系统
前列腺
肥胖
肌萎缩
下尿路症状
泌尿科
内科学
妇科
上尿路
前列腺
风险因素
减肥
尿失禁
脂肪组织
骨骼肌
人口
作者
Zhonghan Zhou,Gongyue Liu,Junjie Ji,Yixi Liu,Limin Liao
标识
DOI:10.1016/j.euros.2025.10.005
摘要
Background and objective This study explores the associations of sarcopenia, obesity, and their coexistence (sarcopenic obesity) with benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). Methods Data from the China Health and Retirement Longitudinal Study (CHARLS) 2011 and 2015 were analyzed. Participants aged ≥45 yr were categorized into four groups: normal, sarcopenia, obesity (defined as body mass index >25 kg/m 2 ), and sarcopenic obesity. LUTS/BPH was assessed according to each patient’s medical history. Logistic regression was used to evaluate the association of obesity, sarcopenia, and sarcopenic obesity with BPH/LUTS. Interaction effects were further assessed to investigate the combined impact of sarcopenia and obesity. Key findings and limitations Among 6236 participants, 17% of those in the sarcopenic obesity group had BPH/LUTS, which is a significantly higher rate than in the other groups. Unadjusted logistic regression analysis showed that obesity (odds ratio [OR] 1.32, 95% confidence interval [CI] 1.10–1.58; p = 0.003) and sarcopenia (OR 1.19, 95% CI 1.06–1.35; p = 0.004) were associated with higher risk of LUTS/BPH. However, after adjusting for other biomarkers, only coexisting sarcopenia and obesity (OR 1.51, 95% 1.01–2.27; p = 0.046) was associated with significantly higher risk of LUTS/BPH, while no association was observed for either sarcopenia alone (OR 0.88, 95% CI 0.67–1.15; p = 0.3) or obesity alone (OR 0.99, 95% CI 0.72–1.35; p = 0.9). Sensitivity analyses confirmed these findings. The interaction between sarcopenia and obesity was significant, with 40% (95% CI 13–56%) of the risk attributed to their combined effect. Conclusions and clinical implications Sarcopenic obesity was independently associated with higher risk of BPH/LUTS among older men in our cohort. Our study highlights the synergistic interaction between sarcopenia and obesity, and suggests a need for comprehensive management of both conditions to reduce the risk of BPH/LUTS. Patient summary We looked at associations between a condition called sarcopenic obesity (obesity and a loss of muscle mass) and benign enlargement of the prostate gland causing urinary problems (called BPH/LUTS for short). We found that sarcopenic obesity is associated with a higher risk of BPH/LUTS in older men.
科研通智能强力驱动
Strongly Powered by AbleSci AI